Financial statements Molecule One
Balance sheet data of MOLECULE ONE
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 674 870,74 | 313 828,22 | 9 013 886,66 | 3 141 171,76 | 2 440 079,80 |
A. Fixed assets | - | - | 306 844,18 | 1 132 841,33 | 1 167 118,56 |
B. Current assets | 674 870,74 | 313 828,22 | 8 705 492,48 | 2 006 780,43 | 1 271 411,24 |
C. Share capital contributions (basic funds) | - | - | 1 550,00 | 1 550,00 | 1 550,00 |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 674 870,74 | 313 828,22 | 9 013 886,66 | 3 141 171,76 | 2 440 079,80 |
A. Equity | 629 417,30 | 99 223,58 | 8 338 759,84 | 2 532 412,85 | 508 724,24 |
B. Liabilities and provisions for liabilities | 45 453,44 | 214 604,64 | 675 126,82 | 608 758,91 | 1 931 355,56 |
I. Long-term liabilities | - | - | - | - | - |
II. Short-term liabilities | - | 214 604,64 | 674 126,82 | 606 558,91 | 1 927 905,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.